跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要聚焦传染病动态与不完整数据建模,未明确对应所列宏观或微观经济计量方向。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Corbin Quick
Rounak Dey
Xihong Lin

不完整数据下理解 COVID-19 疫情动态的回归模型

研究问题
面对漏报、检测不足及感染到报告的时间滞后,如何联合估计多个地区的有效再生数、检出率、发病与患病水平?
方法与思路
作者提出 MERMAID 多层回归模型,联合使用确诊、检测和血清调查数据,并将随机滞后视为缺失数据以 EM 估计。
材料陈述的贡献
摘要称方法允许再生数随地区和时变协变量变化,提供模拟与模型误设敏感性分析,并报告美国疫情的模型估计。
阅读关注点
应核对检出概率与检测指标的关系、血清调查如何约束漏报、滞后分布设定,以及各潜在疫情指标能否分别识别。
阅读边界
仅据 OpenAlex 索引摘要,稿件版本未注明;报告比例属于模型估计,不能据此确定真实感染水平,亦不能推断刊本变化。

原文摘要

Modeling infectious disease dynamics has been critical throughout the COVID-19 pandemic. Of particular interest are the incidence, prevalence, and effective reproductive number (Rt ). Estimating these quantities is challenging due to under-ascertainment, unreliable reporting, and time lags between infection, onset, and testing. We propose a Multilevel Epidemic Regression Model to Account for Incomplete Data (MERMAID) to jointly estimate Rt , ascertainment rates, incidence, and prevalence over time in one or multiple regions. Specifically, MERMAID allows for a flexible regression model of Rt that can incorporate geographic and time-varying covariates. To account for under-ascertainment, we (a) model the ascertainment probability over time as a function of testing metrics and (b) jointly model data on confirmed infections and population-based serological surveys. To account for delays between infection, onset, and reporting, we model stochastic lag times as missing data, and develop an EM algorithm to estimate the model parameters. We evaluate the performance of MERMAID in simulation studies, and assess its robustness by conducting sensitivity analyses in a range of scenarios of model misspecifications. We apply the proposed method to analyze COVID-19 daily confirmed infection counts, PCR testing data, and serological survey data across the United States. Based on our model, we estimate an overall COVID-19 prevalence of 12.5% (ranging from 2.4% in Maine to 20.2% in New York) and an overall ascertainment rate of 45.5% (ranging from 22.5% in New York to 81.3% in Rhode Island) in the United States from March to December 2020. Supplementary materials for this article, including a standardized description of the materials available for reproducing the work, are available as an online supplement.

笔记与分组
相关领域论文